[1] 夏维波,章振林,林华,等.原发性骨质疏松症诊疗指南(2017)[J].中国骨质疏松杂志,2019,25(3):281-309.
[2] 胡阳,宋敏,李凯,等.左归丸及其组方治疗绝经后骨质疏松症的基础研究进展[J].中华中医药学刊,2023,41(12):86-89.
[3] LeBoff MS, Greenspan SL, Insogna KL, et al. The clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2022;33(10):2049-2102.
[4] DING Y, ZENG JC, YIN F, et al. Multicenter Study on Observation of Acute-phase Responses After Infusion of Zoledronic Acid 5 mg in Chinese Women with Postmenopausal Osteoporosis. Orthop Surg. 2017;9(3):284-289.
[5] PENG Z, XU R, YOU Q. Role of Traditional Chinese Medicine in Bone Regeneration and Osteoporosis. Front Bioeng Biotechnol. 2022;10:911326.
[6] 申浩,丁品胜,魏戌,等.基于文献的骨质疏松症中医证候特征研究[J].中国中医基础医学杂志,2018,24(12):1676-1679.
[7] 朱文菊,苏小军,何倩,等.基于肾虚精亏理论探讨类风湿关节炎骨破坏的发生发展机制[J].中医杂志,2024,65(19):2045-2049.
[8] 王伟,万雷,柴爽,等.骨质疏松症的中医病因病机和分期治疗[J].中医正骨,2018,30(2):29-30.
[9] 中华医学会骨质疏松和骨矿盐疾病分会,章振林.原发性骨质疏松症诊疗指南(2022)[J].中国全科医学,2023,26(14):1671-1691.
[10] 张勇,牟健,景远明,等.补肾健脾强骨汤联合唑来膦酸治疗骨质疏松的效果及对激素、骨代谢的影响[J].四川中医,2023,41(12):152-154.
[11] 李宁,黄景辉,邵倩,等.补肾健脾壮骨方对绝经后骨质疏松症患者骨代谢及疗效的影响探究[J].河北中医药学报,2020,35(1):42-44+56.
[12] 柴爽,黄佳纯,王吉利,等.补肾健脾活血方对大鼠绝经后骨质疏松症的防治作用[J].中成药,2019,41(9):2213-2216.
[13] 孔源,宫云昭,王莹,等.补肾健脾方对去卵巢诱导大鼠骨质疏松的作用及其机制研究[J].中华中医药学刊,2021,39(8):175-179+278.
[14] 罗坤灵,吴志方,唐咏,等.补肾健脾方对绝经后骨质疏松症患者血清破骨和成骨相关因子及肠道菌群的影响[J].中国临床研究,2023,36(12):1866-1870.
[15] LLABRE JE, GIL C, AMATYA N, et al. Degradation of Bone Quality in a Transgenic Mouse Model of Alzheimer’s Disease. J Bone Miner Res. 2022;37(12):2548-2565.
[16] LYU HZ, LEE JH. Correlation between two-dimensional micro-CT and histomorphometry for assessment of the implant osseointegration in rabbit tibia model. Biomater Res. 2021;25(1):11.
[17] 苏辉,闫炳翰,王若冲,等.补肾壮骨方干预去卵巢骨质疏松模型大鼠骨代谢及骨密度的变化[J].中国组织工程研究,2023,27(28):4507-4512.
[18] BOUXSEIN ML, BOYD SK, CHRISTIANSEN BA, et al. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010;25(7):1468-1486.
[19] 梁文娜,李西海,李灿东.绝经后骨质疏松的核心病机-骨痿[J].中国老年学杂志,2015,35(18):5333-5335.
[20] 笪巍伟,唐德志,赵永见,等.探“先天、后天”理论在促进去卵巢小鼠骨质疏松性骨折愈合中的作用[J].中华中医药杂志,2017,32(6):2647-2651.
[21] 陈海,冯康虎,陈志伟,等.基于中医肝肾二脏的膝骨关节炎研究述评[J].中国中医药信息杂志,2021,28(1):142-144.
[22] 汪小健,李少广,王彭禾,等.基于“髓系骨病”理论论治膝骨关节炎[J].中华中医药杂志,2021,36(11):6500-6503.
[23] WONG L, MCMAHON LP. Crosstalk between bone and muscle in chronic kidney disease. Front Endocrinol (Lausanne). 2023;14:1146868.
[24] YATSONSKY II D, PAN K, SHENDGE VB, et al. Linkage of microbiota and osteoporosis: A mini literature review. World J Orthop. 2019;10(3):123-127.
[25] 刘鸿雁,李剑,翟羽,等.健脾补肾活血方治疗女性绝经后骨质疏松效果及对血清1型原胶原氨基末端前肽、β-胶原特殊序列水平的影响[J].中国老年学杂志,2018,38(2):431-432.
[26] 李绍烁,顾一丹,邵阳,等.CiteSpace知识图谱可视化分析中医药防治绝经后骨质疏松症[J].中国组织工程研究,2020,24(26):4224-4230.
[27] ZHOU D, XIA X, LING J, et al. Regulating spleen and stomach can improve bone and joint function of knee osteoarthritis patients complicated with osteoporosis. Am J Transl Res. 2023;15(9):5769-5777.
[28] 黄晋,李建国,谢兴文,等.中药复方治疗绝经后骨质疏松症的临床研究概况[J].中国骨质疏松杂志,2019,25(2):277-280.
[29] LI X, YU C, HU Y, et al. New Application of Psoralen and Angelicin on Periodontitis With Anti-bacterial, Anti-inflammatory, and Osteogenesis Effects. Front Cell Infect Microbiol. 2018;8:178.
[30] HASSANEIN EHM, SAYED AM, HUSSEIN OE, et al. Coumarins as Modulators of the Keap1/Nrf2/ARE Signaling Pathway. Oxid Med Cell Longev. 2020;2020:1675957.
[31] 董熠,刘丽佳,韩潞雯,等.香豆素类化学成分的药理作用及毒性机制研究进展[J].中草药,2023,54(16):5462-5472.
[32] 金垚,徐鹏辉,卞泗善,等.淫羊藿通过ICA-miR-335-5p轴缓解骨质疏松症的生物信息学分析及实验研究[J].中医药导报,2023,29(2):1-7+13.
[33] SHI S, WANG F, HUANG Y, et al. Epimedium for Osteoporosis Based on Western and Eastern Medicine: An Updated Systematic Review and Meta-Analysis. Front Pharmacol. 2022;13:782096.
[34] DESMAWATI D, SULASTRI D. Phytoestrogens and Their Health Effect. Open Access Maced J Med Sci. 2019;7(3):495-499.
[35] 房敏,赵冠宇,李泉洋,等.经典名方四物汤化学成分、药理作用、临床应用研究进展及质量标志物预测分析[J].中华中医药学刊,2024,42(7):154-161.
[36] 袁雨露,杨桢,丁薇,等.中药抗骨质疏松作用及机制探讨[J].中国实验方剂学杂志,2024,30(4):290-298.
[37] WANG X, TANG P, YANG K, et al. Regulation of bone homeostasis by traditional Chinese medicine active scaffolds and enhancement for the osteoporosis bone regeneration. J Ethnopharmacol. 2024;329:118141.
[38] 李玉洁,刘拓,王璐琪,等.符合中医药特点的中药药效评价创新方法:基于五脏关联规律的中药复方“同治/同调”药效优势表征体系构建思考[J].中国实验方剂学杂志,2024,30(23):19-26.
[39] WANG L, HUANG X, QIN J, et al. The Role of Traditional Chinese Medicines in the Treatment of Osteoporosis. Am J Chin Med. 2024;52(4):949-986.
[40] 雷欣东,于慧,龙琼,等.绝经后骨质疏松症发病机制研究进展[J].中国骨质疏松杂志,2021,27(11):1681-1684.
[41] BROWN JP, DON-WAUCHOPE A, DOUVILLE P, et al. Current use of bone turnover markers in the management of osteoporosis. Clin Biochem. 2022;109-110:1-10.
[42] 肖华,卓芬,黄娟娟,等.血清骨代谢指标及细胞因子与老年男性骨质疏松的相关性[J].中华骨质疏松和骨矿盐疾病杂志,2019,12(2):120-125.
[43] CUI H, LI J, LI X, et al. TNF-α promotes osteocyte necroptosis by upregulating TLR4 in postmenopausal osteoporosis. Bone. 2024;182:117050.
[44] YAO Q, HE L, BAO C, et al. The role of TNF-α in osteoporosis, bone repair and inflammatory bone diseases: A review. Tissue Cell. 2024;89:102422.
[45] 侍方,倪磊.粉防己碱靶向TNF-α介导PI3K/Akt/NF-κB信号通路抑制骨质疏松症的作用研究[J].解放军医药杂志,2021,33(9):6-10.
[46] HWANG JM, LEE MH, KWON Y, et al. In Vitro and In Vivo Bone-Forming Effect of a Low-Molecular-Weight Collagen Peptide. J Microbiol Biotechnol. 2024;34(2):415-424.
[47] 屈萌艰,彭昕珂,彭婷,等.电针对老年骨质疏松大鼠骨组织中组织蛋白酶K及Ⅰ型胶原表达的影响[J].中国老年学杂志,2024,44(15):3679-3683.
[48] 杨恬恬,钟越彤,吴万垠,等.基于免疫编辑假说探讨中医阴阳平衡与肿瘤免疫[J].中医肿瘤学杂志,2022,4(4):30-36.
[49] 史有阳,杨瑞,韩向晖,等.基于“阴阳平衡”理论探讨中医药对相关疾病线粒体融合-分裂的影响[J].中国医药导报,2020,17(3):132-134+158. |